Professor of Translational Virotherapies, Cardiff University.

As Head of Solid Cancers within Cardiff University’s Division of Cancer and Genetics, Professor Parker specializes in developing tumour selective virotherapies, that target and infect cancer cells without affecting normal cells. His work, and the potential treatments it heralds, is regularly featured in the media and he uses the importance of (and excitement surrounding) his work in outreach and engagement activities.